Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes.

Ting-Ting GengJun-Xiang ChenYan-Feng Zhou Qi LuZhenzhen WanLiegang LiuAn PanGang Liu

Published in: The Journal of clinical endocrinology and metabolism (2022)

Our data suggested that PPI use was associated with higher risks of CVD events and mortality among patients with T2D. The benefits and risks of PPI use should be carefully balanced among patients with T2D, and monitoring of adverse CVD events during PPI therapy should be enhanced.

Keyphrases

human health
cardiovascular disease
protein protein
cardiovascular events
risk assessment
risk factors
type diabetes
electronic health record
emergency department
big data
coronary artery disease
metabolic syndrome
mesenchymal stem cells
bone marrow
data analysis